Sequenom to Present at Leerink Swann Emerging Products and Applications in Life Science...

Sequenom to Present at Leerink Swann Emerging Products and Applications in Life Science Tools Conference

SAN DIEGO--(Business Wire)--
Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic
analysis solutions, today announced that Harry Stylli, Ph.D.,
President and Chief Executive Officer, is scheduled to present at the
Leerink Swann Emerging Products and Applications in Life Science
Tools: 3rd Annual Roundtable Conference on Thursday, August 7th at
3:00 p.m. Eastern time (12:00 p.m. Pacific time). The conference is
being held at The New York Palace Hotel in New York City.

A live webcast of the presentation will be available on the
Company's Web site at www.sequenom.com, and replays will be available
for 14 days starting approximately three hours after the initial
presentation.

About Sequenom

Sequenom is committed to providing the best genetic analysis
products that translate the results of genomic science into solutions
for noninvasive prenatal diagnostics, biomedical research,
translational research and molecular medicine applications, and for
research conducted in the agro (agricultural and livestock) industry.
The Company's proprietary MassARRAY(R) system is a high-performance
(in speed, accuracy and cost efficiency) DNA analysis platform that
quantitatively and precisely measures genetic target material and
variations. The Company has exclusively licensed intellectual property
rights for the development and commercialization of non-invasive
prenatal genetic tests for use with the MassARRAY system and other
platforms.

Sequenom(R) and MassARRAY(R) are trademarks of Sequenom, Inc.

Company Contact
Sequenom, Inc.
Paul W. Hawran, Chief Financial Officer, 858-202-9000
or
Investor Relations Contact
Lippert/Heilshorn & Associates
Jody Cain or Kevin Mc Cabe, 310-691-7100
jcain@lhai.com
kmccabe@lhai.com

Copyright Business Wire 2008